GSK962040 50 mg
Sponsors
GlaxoSmithKline
Conditions
Gastroparesis
Phase 2
The Effect of Single Doses of the Motilin Receptor Agonist GSK962040 in Type I Diabetic Patients With Gastroparesis
CompletedNCT00861809
Start: 2009-06-30End: 2010-11-30Updated: 2017-01-30
Nutritional Adequacy Therapeutic Enhancement in the Critically Ill. The NUTRIATE Study
TerminatedNCT01934192
Start: 2014-04-04End: 2016-07-08Updated: 2017-12-11